Pacira to Report 2024 Financial Results on Thursday February 27, 2025
Pacira BioSciences (PCRX) has announced it will release its fourth quarter and full-year 2024 financial results after U.S. markets close on Thursday, February 27, 2025. The company will host a conference call and webcast at 4:30 p.m. ET on the same day.
Interested participants can pre-register for the Q&A session via telephone, and all registrants will receive dial-in information and a PIN for call access. The conference call will also be available as a webcast through the 'Events' page on Pacira's investor website. A replay of the webcast will be accessible on the company's website for approximately two weeks following the call.
Pacira BioSciences (PCRX) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura dei mercati statunitensi giovedì 27 febbraio 2025. L'azienda ospiterà una conferenza telefonica e una diretta web alle 16:30 ET lo stesso giorno.
I partecipanti interessati possono preregistrarsi per la sessione di domande e risposte tramite telefono, e tutti i registrati riceveranno informazioni per il collegamento e un PIN per accedere alla chiamata. La conferenza telefonica sarà disponibile anche come webcast attraverso la pagina 'Eventi' sul sito web per investitori di Pacira. Una registrazione del webcast sarà accessibile sul sito dell'azienda per circa due settimane dopo la chiamata.
Pacira BioSciences (PCRX) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre de los mercados estadounidenses el jueves 27 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y una transmisión en vivo a las 4:30 p.m. ET el mismo día.
Los participantes interesados pueden preinscribirse para la sesión de preguntas y respuestas por teléfono, y todos los registrados recibirán información de acceso y un PIN para unirse a la llamada. La conferencia telefónica también estará disponible como webcast a través de la página de 'Eventos' en el sitio web de inversores de Pacira. Una repetición de la transmisión estará accesible en el sitio web de la empresa durante aproximadamente dos semanas después de la llamada.
Pacira BioSciences (PCRX)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 27일 목요일 미국 시장 폐장 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 전화 회의 및 웹캐스트를 개최합니다.
참여를 원하는 사람들은 전화로 Q&A 세션에 사전 등록할 수 있으며, 모든 등록자는 전화 접속을 위한 다이얼 인 정보와 PIN을 받게 됩니다. 전화 회의는 Pacira의 투자자 웹사이트의 '이벤트' 페이지를 통해 웹캐스트로도 제공됩니다. 웹캐스트의 재생은 통화 후 약 2주 동안 회사 웹사이트에서 접근할 수 있습니다.
Pacira BioSciences (PCRX) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 après la fermeture des marchés américains le jeudi 27 février 2025. L'entreprise organisera une conférence téléphonique et un webinaire à 16h30 ET le même jour.
Les participants intéressés peuvent s'inscrire à l'avance pour la session de questions et réponses par téléphone, et tous les inscrits recevront des informations de connexion et un code PIN pour accéder à l'appel. La conférence téléphonique sera également disponible en tant que webinaire via la page 'Événements' sur le site des investisseurs de Pacira. Une rediffusion du webinaire sera accessible sur le site de l'entreprise pendant environ deux semaines après l'appel.
Pacira BioSciences (PCRX) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 nach Schließung der US-Märkte am Donnerstag, den 27. Februar 2025, veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten.
Interessierte Teilnehmer können sich telefonisch für die Q&A-Session vorab registrieren, und alle registrierten Teilnehmer erhalten Informationen zur Einwahl und eine PIN für den Zugang zum Anruf. Die Telefonkonferenz wird auch als Webcast über die Seite 'Veranstaltungen' auf der Investorenseite von Pacira verfügbar sein. Eine Wiederholung des Webcasts wird auf der Unternehmenswebsite für etwa zwei Wochen nach dem Anruf zugänglich sein.
- None.
- None.
PARSIPPANY, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its fourth quarter and year ended December 31, 2024 financial results after the close of the U.S. markets on Thursday February 27, 2025. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.
For listeners who wish to participate in the question and answer session via telephone, please pre-register here. All registrants will receive dial-in information and a PIN allowing them to access the live call. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com. For those unable to participate in the live call, a replay of the webcast will be available on the Pacira website for approximately two weeks following the call.
About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing the development of PCRX-201, a novel locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit www.pacira.com.
FAQ
When will Pacira (PCRX) release its Q4 and FY 2024 earnings?
What time is Pacira's (PCRX) Q4 2024 earnings call?
How can investors access Pacira's (PCRX) Q4 2024 earnings call?
How long will Pacira's (PCRX) Q4 2024 earnings call replay be available?
